Q&A With John DeLuca From the Kessler Foundation: Testing and Diagnosing Cognitive Impairment Key in Multiple Sclerosis Treatment

While many areas of multiple sclerosis treatment have made progress in recent years working to help patients through issues with cognition is still an inexact science though work is being done to correct that.John DeLuca, PhD, Senior Vice President for Research at the Kessler Foundation addressed what has been done in the field for this issue as well as what work remains to be done during the ECTRIMS conference in Barcelona.